Oxford Events, the new replacement for OxTalks, will launch on 16th March. From now until the launch of Oxford Events, new events cannot be published or edited on OxTalks while all existing records are migrated to the new platform. The existing OxTalks site will remain available to view during this period.
From 16th, Oxford Events will launch on a new website: events.ox.ac.uk, and event submissions will resume. You will need a Halo login to submit events. Full details are available on the Staff Gateway.
Mathematical and computational techniques can improve our understanding of diseases. In this talk, I’ll present ways in which data from cancer patients can be combined with mathematical modelling and used to improve cancer treatments.
Given the variability in individual responses to cancer treatments, agent-based modelling has been a useful technique for accurately capturing cellular behaviours that may lead to stochasticity in patient outcomes. Using a hybrid agent-based model and partial differential equation system, we developed a model for brain cancer (glioblastoma) growth informed by ex-vivo patient samples. Extending the model to capture patient treatment with an oncolytic virus rQNestin, we used our model to propose reasons for treatment failure, which was later confirmed with further patient samples. More recently, we extended this model to investigate the effectiveness of combination treatments (chemotherapy, virotherapy and immunotherapy) informed by individual patient imaging mass cytometry.
This talk hopes to provide examples of ways mathematical and computational modelling can be used to run “virtual” clinical trials with the goal of obtaining more effective treatments for diseases.
